# Benitec Biopharma Inc.: Form 8-K, filed Mar 27, 2025

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: 8-K
- Filed: 2025-03-27
- Accepted by EDGAR: Mar 27, 2025, 17:10 ET
- Period: 2025-03-26
- Accession: 0001193125-25-065613
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000119312525065613/d933210d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000119312525065613/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000119312525065613/d933210d8k.htm

Filed Mar 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-065613. Last ingested by Listed: Oct 28, 2026, 08:04 ET. No prices; not investment advice.